Endpoints News 生物医药· Elizabeth Cairns·· 11 天前AI 评分50
礼来在肥胖药物治疗睡眠呼吸暂停方面取得新进展
#AHA26: Lilly gets another sleep apnea win, this time with obesity pill
AI 导读
礼来计划寻求其肥胖药物在阻塞性睡眠呼吸暂停上的批准,基于 III 期试验的积极结果。
正文
Eli Lilly plans to seek approval of its obesity med in obstructive sleep apnea after a positive Phase 3 trial, potentially giving it a new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news